BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
BAY38-9456 - Pivotal Trial for Diabetes Patient
Phase 3
Completed
- Conditions
- Diabetes MellitusErectile Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 790
- Registration Number
- NCT00678704
A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.
Phase 2
Terminated
- Conditions
- Carcinoma, Renal Cell
- Interventions
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 16
- Registration Number
- NCT00678288
Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Phase 4
Completed
- Conditions
- Urinary Tract Infection
- Interventions
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- Bayer
- Target Recruit Count
- 276
- Registration Number
- NCT00676533
A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)
Phase 3
Completed
- Conditions
- Gastric AcidHuman Experimentation
- Interventions
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 60
- Registration Number
- NCT00674115
Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D
Phase 2
Completed
- Conditions
- Contraceptives, Oral
- Interventions
- Drug: Yasminelle (SH T 00186 D)Drug: YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 105
- Registration Number
- NCT00673686
Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension
Phase 4
Completed
- Conditions
- Hypertension
- Interventions
- Drug: Coracten
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 43
- Registration Number
- NCT00672113
BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Phase 3
Completed
- Conditions
- Bacterial Infections
- Interventions
- First Posted Date
- 2008-05-01
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 497
- Registration Number
- NCT00670215
Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
- First Posted Date
- 2008-05-01
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 180
- Registration Number
- NCT00669994
Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia
Phase 4
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-04-29
- Last Posted Date
- 2014-12-17
- Lead Sponsor
- Bayer
- Target Recruit Count
- 348
- Registration Number
- NCT00668135
Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox
- First Posted Date
- 2008-04-29
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 192
- Registration Number
- NCT00668304